These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35324518)

  • 1. CircFOXK2 enhances tumorigenesis and immune evasion in non-small cell lung cancer by miR-485-5p/PD-L1 axis.
    Zhang N; Fan J; Deng Z
    Anticancer Drugs; 2022 Jun; 33(5):437-447. PubMed ID: 35324518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Circular RNA circFOXK2 Enhances the Tumorigenesis of Non-Small Cell Lung Cancer Through the miR-149-3p/IL-6 Axis.
    Xiang T; Chen L; Wang H; Yu T; Li T; Li J; Yu W
    Biochem Genet; 2024 Feb; 62(1):95-111. PubMed ID: 37256441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA circ-CPA4/ let-7 miRNA/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC).
    Hong W; Xue M; Jiang J; Zhang Y; Gao X
    J Exp Clin Cancer Res; 2020 Aug; 39(1):149. PubMed ID: 32746878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNA circ_0101675 Promotes NSCLC Cell Proliferation, Migration, Invasion, Angiogenesis and Immune Evasion by Sponging miR-607/PDL1 Axis.
    Lu W; Li L; Li L; Guo N; Ma X
    Biochem Genet; 2024 Jun; 62(3):1539-1555. PubMed ID: 37646893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N
    Liu Z; Wang T; She Y; Wu K; Gu S; Li L; Dong C; Chen C; Zhou Y
    Mol Cancer; 2021 Aug; 20(1):105. PubMed ID: 34416901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circular RNA circ_0003028 contributes to tumorigenesis by regulating GOT2 via miR-1298-5p in non-small cell lung cancer.
    Guan H; Sun C; Gu Y; Li J; Ji J; Zhu Y
    Bioengineered; 2021 Dec; 12(1):2326-2340. PubMed ID: 34077306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circ_0014235 confers Gefitinib resistance and malignant behaviors in non-small cell lung cancer resistant to Gefitinib by governing the miR-146b-5p/YAP/PD-L1 pathway.
    Niu R; Li D; Chen J; Zhao W
    Cell Cycle; 2022 Jan; 21(1):86-100. PubMed ID: 34919024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 9. lncRNA PSMA3-AS1 promotes the progression of non-small cell lung cancer through targeting miR-17-5p/PD-L1.
    Cheng G; Li Y; Liu Z; Song X
    Adv Clin Exp Med; 2021 Oct; 30(10):1043-1050. PubMed ID: 34610219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CircSLC25A16 facilitates the development of non-small-cell lung cancer through the miR-335-5p/CISD2 axis.
    Fu Y; Chen B; Gao T; Wang Z
    Thorac Cancer; 2024 Jul; 15(19):1490-1501. PubMed ID: 38803052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circ_0072088 promotes the development of non-small cell lung cancer via the miR-377-5p/NOVA2 axis.
    Tan Z; Cao F; Jia B; Xia L
    Thorac Cancer; 2020 Aug; 11(8):2224-2236. PubMed ID: 32524752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA-20b-5p overexpression combing Pembrolizumab potentiates cancer cells to radiation therapy via repressing programmed death-ligand 1.
    Jiang K; Zou H
    Bioengineered; 2022 Jan; 13(1):917-929. PubMed ID: 34968160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA hsa_circ_0068252 Functions in Cisplatin Resistance and Immune Response via miR-1304-5p/PD-L1 Axis in Non-Small Cell Lung Cancer.
    Li J; Xu J; Wu G; Ren Y; Wang X; Zhang Q
    Chemotherapy; 2022; 67(4):223-233. PubMed ID: 35649347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circ_0011292 Enhances Paclitaxel Resistance in Non-Small Cell Lung Cancer by Regulating miR-379-5p/TRIM65 Axis.
    Guo C; Wang H; Jiang H; Qiao L; Wang X
    Cancer Biother Radiopharm; 2022 Mar; 37(2):84-95. PubMed ID: 32833503
    [No Abstract]   [Full Text] [Related]  

  • 15. LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p/programmed death-ligand 1 axis.
    Wei S; Wang K; Huang X; Zhao Z; Zhao Z
    Int J Immunopathol Pharmacol; 2019; 33():2058738419859699. PubMed ID: 31240979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CircRNA VIM silence synergizes with sevoflurane to inhibit immune escape and multiple oncogenic activities of esophageal cancer by simultaneously regulating miR-124/PD-L1 axis.
    Gao C; Xu YJ; Qi L; Bao YF; Zhang L; Zheng L
    Cell Biol Toxicol; 2022 Oct; 38(5):825-845. PubMed ID: 34018092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soy isoflavone genistein inhibits hsa_circ_0031250/miR-873-5p/FOXM1 axis to suppress non-small-cell lung cancer progression.
    Yu Y; Xing Y; Zhang Q; Zhang Q; Huang S; Li X; Gao C
    IUBMB Life; 2021 Jan; 73(1):92-107. PubMed ID: 33159503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CircRNA CDR1as knockdown inhibits progression of non-small-cell lung cancer by regulating miR-219a-5p/SOX5 axis.
    Li Y; Zhang J; Pan S; Zhou J; Diao X; Liu S
    Thorac Cancer; 2020 Mar; 11(3):537-548. PubMed ID: 31917898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CircVAPA exerts oncogenic property in non-small cell lung cancer by the miR-876-5p/WNT5A axis.
    Zhao Y; Dai Q; Fu X; Chen Q; Tang Y; Gao X; Zhou Q
    J Gene Med; 2021 Jun; 23(6):e3325. PubMed ID: 33619796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA PRNCR1 modulates non-small cell lung cancer cell proliferation, apoptosis, migration, invasion, and EMT through PRNCR1/miR-126-5p/MTDH axis.
    Guo R; Hu T; Liu Y; He Y; Cao Y
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 31912882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.